Stokes Family Office’s iShares iBonds Dec 2035 Term Corporate ETF IBCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
44,950
+18,950
+73% +$485K 0.13% 114
2026
Q1
$667K Buy
26,000
+4,000
+18% +$104K 0.07% 168
2025
Q4
$571K Buy
+22,000
New +$573K 0.05% 180

Other funds holding IBCA

Stokes Family Office's IBCA Position: Q2 2026 in Review

Stokes Family Office increased its iShares iBonds Dec 2035 Term Corporate ETF (IBCA) stake by 73% in Q2 2026, buying an estimated $485K and bringing the position to 44,950 shares worth $1.15M. The position accounts for 0.13% of the portfolio, ranked #114.

Stokes Family Office first reported a position in IBCA in Q4 2025 and has held it in 3 quarters since. 94 funds tracked by Wall St. Rank hold IBCA as of Q2 2026.

  • Stokes Family Office held 44,950 shares of iShares iBonds Dec 2035 Term Corporate ETF worth $1.15M as of Q2 2026.
  • Stokes Family Office bought 18,950 iShares iBonds Dec 2035 Term Corporate ETF shares in Q2 2026, an estimated $485K.
  • iShares iBonds Dec 2035 Term Corporate ETF made up 0.13% of Stokes Family Office's portfolio in Q2 2026, its #114 holding.
  • Stokes Family Office first reported a position in iShares iBonds Dec 2035 Term Corporate ETF in Q4 2025 and has held it in 3 quarters since.
  • 94 funds tracked by Wall St. Rank held iShares iBonds Dec 2035 Term Corporate ETF as of Q2 2026.

Based on Stokes Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.